Medartis AG
Medartis is a leading manufacturer and provider of innovative surgical fixation solutions for bone fractures and reconstructive surgeries in upper and lower extremities and the craniomaxillofacial region. Established in 1997 and headquartered in Basel, Switzerland, Medartis is committed to advancing surgical precision, patient care, and continuous education through cutting-edge implants, comprehensive product portfolios, clinical expertise, and innovative solutions such as the CMX and CMF systems. The company aims to restore quality of life for patients worldwide by collaborating closely with healthcare professionals and surgeons.
Industries
Nr. of Employees
large (251-1000)
Medartis AG
Hochbergerstrasse 60E, 4057 Basel, Switzerland
Patents
Products
Modular implant system portfolios for extremities and cranio‑maxillofacial surgery
Portfolios of plates, screws and matched instruments designed for hand, wrist, forearm, elbow, shoulder, foot, ankle and cranio‑maxillofacial indications to support fixation and reconstruction across multiple anatomical regions.
Modular implant system portfolios for extremities and cranio‑maxillofacial surgery
Portfolios of plates, screws and matched instruments designed for hand, wrist, forearm, elbow, shoulder, foot, ankle and cranio‑maxillofacial indications to support fixation and reconstruction across multiple anatomical regions.
Services
Design and production of patient‑specific implants, saw guides and drill guides for complex cases, supported by an online portal for order submission, authenticated review and project tracking.
Collaboration with clinicians for clinical investigations, hands‑on workshops, cadaver labs, training videos and clinician feedback channels to inform product development.
Local subsidiary offices and distributor channels providing sales, order support, distributor onboarding and region‑specific product availability information.
Centralized online delivery of product information, electronic instructions for use, ordering catalogs, certificates and training videos with language and region filtering; includes embedded external media and consent‑controlled analytics.
Online intake process for external idea submissions to evaluate and potentially incorporate novel treatment concepts into the development pipeline.
Design and production of patient‑specific implants, saw guides and drill guides for complex cases, supported by an online portal for order submission, authenticated review and project tracking.
Collaboration with clinicians for clinical investigations, hands‑on workshops, cadaver labs, training videos and clinician feedback channels to inform product development.
Local subsidiary offices and distributor channels providing sales, order support, distributor onboarding and region‑specific product availability information.
Centralized online delivery of product information, electronic instructions for use, ordering catalogs, certificates and training videos with language and region filtering; includes embedded external media and consent‑controlled analytics.
Online intake process for external idea submissions to evaluate and potentially incorporate novel treatment concepts into the development pipeline.
Expertise Areas
- Patient‑specific implant planning and digital manufacturing
- Orthopaedic and cranio‑maxillofacial implant systems and instrumentation engineering
- Fixation hardware and screw interface design
- Topology optimisation and 3D implant modelling
Key Technologies
- Additive manufacturing for patient‑specific implants
- Topology optimisation and 3D mesh modelling
- Locking plate fixation design and screw interface engineering
- Guided instrumentation and drill‑guide systems
News & Updates
The shareholders of Medartis Holding AG approved all proposals of the Board of Directors with a majority exceeding 94.0%.
In 2024, Medartis reported total sales of CHF 224.8 million, with core sales increasing by 11.7%.
The company launched a new, customer-centric website to enhance user experience.
Medartis announced the latest addition to the APTUS Hand portfolio, including new plates, screws, and instruments.
Shareholders approved all proposals with a significant majority.
Introduction of the latest dorsal olecranon plates in the APTUS Elbow portfolio.
The shareholders of Medartis Holding AG approved all proposals of the Board of Directors with a majority exceeding 94.0%.
In 2024, Medartis reported total sales of CHF 224.8 million, with core sales increasing by 11.7%.
The company launched a new, customer-centric website to enhance user experience.
Medartis announced the latest addition to the APTUS Hand portfolio, including new plates, screws, and instruments.
Shareholders approved all proposals with a significant majority.
Introduction of the latest dorsal olecranon plates in the APTUS Elbow portfolio.